169 related items for PubMed ID: 17302055
1. [Study on correlation of blood-stasis syndrome and its accompanied syndromes with pathological changes showed in coronary angiography and restenosis after percutaneous coronary intervention].
Xu H, Lu XY, Chen KJ.
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Jan; 27(1):8-13. PubMed ID: 17302055
[Abstract] [Full Text] [Related]
2. [Effect of Tongguan capsule on post-intervention patients of coronary heart disease with qi-deficiency and blood stasis syndrome].
Li J, Zhang MZ, Chen BJ.
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Jan; 28(1):32-5. PubMed ID: 18418966
[Abstract] [Full Text] [Related]
3. [Clinical study on effect of xiongshao capsule on restenosis after percutaneous coronary intervention].
Lu XY, Shi DZ, Xu H.
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Jan; 26(1):13-7. PubMed ID: 16466165
[Abstract] [Full Text] [Related]
4. A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule in preventing restenosis after percutaneous coronary intervention: a subgroup analysis of senile patients.
Shang QH, Xu H, Lu XY, Wen C, Shi DZ, Chen KJ.
Chin J Integr Med; 2011 Sep; 17(9):669-74. PubMed ID: 21910067
[Abstract] [Full Text] [Related]
5. [Clinical effect of Xiongshao capsule on preventing restenosis post-PTCA or/and stenting].
Xu H, Shi D, Chen K.
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Jul; 20(7):494-7. PubMed ID: 11789203
[Abstract] [Full Text] [Related]
6. [Turbid-phlegm is an important pathogenesis of restenosis after percutaneous transluminal coronary intervention].
Wang DY, Jin HG.
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Aug; 25(8):750-3. PubMed ID: 16152841
[Abstract] [Full Text] [Related]
7. [A randomized double-blinded controlled trial of Xuefu Zhuyu Capsule on short-term quality of life in unstable anginal patients with blood-stasis syndrome after percutaneous coronary intervention].
Chu FY, Wang J, Sun XW, Xing YW, Yao KW, Wang SH, Li ZZ.
Zhong Xi Yi Jie He Xue Bao; 2009 Aug; 7(8):729-35. PubMed ID: 19671410
[Abstract] [Full Text] [Related]
8. Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
Maresta A, Balducelli M, Latini R, Bernardi G, Moccetti T, Sosa C, Barlera S, Varani E, Ribeiro da Silva EE, Monici Preti A, Maggioni AP, STARC II Investigators.
Catheter Cardiovasc Interv; 2005 Mar; 64(3):375-82. PubMed ID: 15736248
[Abstract] [Full Text] [Related]
9. [Study on changes of TCM syndrome in patients with coronary heart disease before and after intervention treatment].
Chen BJ, Pan ZQ, Su XX.
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Aug; 27(8):689-91. PubMed ID: 17879529
[Abstract] [Full Text] [Related]
10. Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: the randomized, double-blind, placebo-controlled, multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events After Angioplasty (VESPA) Trial.
Bestehorn HP, Neumann FJ, Büttner HJ, Betz P, Stürzenhofecker P, von Hodenberg E, Verdun A, Levai L, Monassier JP, Roskamm H.
J Am Coll Cardiol; 2004 Jun 16; 43(12):2160-5. PubMed ID: 15193674
[Abstract] [Full Text] [Related]
11. [Effect of liangxue shengji recipe on incidence of post-percutaneous coronary intervention restenosis and adverse cardiovascular events].
Cui XY, Wu Y, Nong YB.
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jan 16; 30(1):30-2. PubMed ID: 20353028
[Abstract] [Full Text] [Related]
12. XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China.
Chen KJ, Shi DZ, Xu H, Lü SZ, Li TC, Ke YN, Zhang MZ, Lu XY, Sun RY, You SJ.
Chin Med J (Engl); 2006 Jan 05; 119(1):6-13. PubMed ID: 16454975
[Abstract] [Full Text] [Related]
13. Abciximab and angiographic restenosis after coronary stent placement. Analysis of the angiographic substudy of ISAR-REACT--a double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high loading dose of clopidogrel.
Schühlen H, Kastrati A, Mehilli J, Hausleiter J, Dirschinger J, Dotzer F, Bollwein H, Schömig A.
Am Heart J; 2006 Jun 05; 151(6):1248-54. PubMed ID: 16781230
[Abstract] [Full Text] [Related]
14. [Relationship among peripheral leucocytes, coronary stenosis and Chinese medicine syndromes in patients with coronary heart disease].
Wang J, Li J, Yang G.
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Feb 05; 30(2):130-2. PubMed ID: 20462036
[Abstract] [Full Text] [Related]
15. Oral administration of glycine in the prevention of restenosis after coronary angioplasty. A double blind placebo controlled randomized feasibility trial evaluating safety and efficacy of glycine in the prevention of restenosis after angioplasty.
Khan M, Ron Van Der Wieken L, Riezebos RK, Tijssen JG, Kiemeneij F, Slagboom T, Laarman GJ.
Acute Card Care; 2006 Feb 05; 8(1):58-64. PubMed ID: 16720430
[Abstract] [Full Text] [Related]
16. [Correlation analysis on blood stasis syndrome, clinical features and renal pathology in 174 patients with primary glomerular diseases].
Li S, Wang SX, Rao XR.
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Jun 05; 27(6):487-91. PubMed ID: 17633356
[Abstract] [Full Text] [Related]
17. Provisional stenting for multivessel PCI.
Han B, Liu L, Aboud M, Nahir M, Hasin Y.
Int J Cardiovasc Intervent; 2005 Jun 05; 7(1):46-51. PubMed ID: 16019615
[Abstract] [Full Text] [Related]
18. [Relationship between coronary angiography and syndrome differentiation type of TCM].
Ma XC, Yin TY, Chen KJ.
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Sep 05; 21(9):654-6. PubMed ID: 12575549
[Abstract] [Full Text] [Related]
19. [Effect of shuxuetong in preventing restenosis after intracoronary stenting].
Li AH, Gong KZ, Yan JF, Sun X, Feng Y, Zhang Z.
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Oct 05; 24(10):879-81. PubMed ID: 15553817
[Abstract] [Full Text] [Related]
20. Geographical differences in the rates of angiographic restenosis and ischemia-driven target vessel revascularization after percutaneous coronary interventions: results from the Prevention of Restenosis With Tranilast and its Outcomes (PRESTO) Trial.
Singh M, Williams BA, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny WF, Cutlip DE, Holmes DR.
J Am Coll Cardiol; 2006 Jan 03; 47(1):34-9. PubMed ID: 16386661
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
